Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Jennifer Harrar

Nurse Practitioner, Acute Care Camden, NJ Nurse Practitioner

NPI 1376805788 CMS profile 10588359

3 Cooper Plz Rm 502, Camden, NJ 08103

Open in the dashboard

General payments

$15,752

162 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jennifer Harrar of Camden, NJ is reported in the CMS Open Payments database as having received $15,752 across 162 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Nurse Practitioner, Acute Care profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,209 41
2024 General $3,041 32
2023 General $4,817 48
2022 General $2,274 22
2021 General $1,411 19

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jennifer Harrar
  • Nurse Practitioner, Acute Care median
  • Middle half of Nurse Practitioner, Acute Care
  • National median

In program year 2025, general payments to Jennifer Harrar were reported at $4,209. Among 11,827 Nurse Practitioner, Acute Care profiles paid that year, the median was $152 and the middle half received between $48 and $458.

Show as a table
Year Jennifer Harrar Nurse Practitioner, Acute Care median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $1,411 $123 $38–$327 $132
2022 $2,274 $130 $44–$369 $149
2023 $4,817 $144 $49–$410 $160
2024 $3,041 $146 $48–$433 $164
2025 $4,209 $152 $48–$458 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Edwards Lifesciences Corporation $7,807 82 payments
  2. Medtronic, Inc. $4,910 46 payments
  3. Abbott Laboratories $2,555 19 payments
  4. Atricure, Inc. $136 3 payments
  5. AstraZeneca Pharmaceuticals LP $92 1 payment
  6. Shockwave Medical, Inc $48 1 payment
  7. Pfizer Inc. $45 3 payments
  8. Integra LifeSciences Corporation $42 1 payment
  9. Boston Scientific Corporation $37 2 payments
  10. Baxter Healthcare $26 1 payment
  11. Other $55 3 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $7,876 120 payments
  2. Travel and Lodging $7,876 42 payments
Products named General payments · program years 2021–2025
  1. COREVALVE EVOLUT R $4,798 45 payments
  2. MITRACLIP Vascular $1,518 12 payments
  3. Edwards SAPIEN 3 Ultra Transcatheter Heart Valve $1,394 17 payments
  4. SAPIEN 3 Ultra RESILIA $1,048 20 payments
  5. MITRACLIP Structural Heart $882 6 payments
  6. MITRACLIP Vascular $155 1 payment
  7. CoreValve Evolut $112 1 payment
  8. AtriCure cryoICE cryoSPHERE Cryoablation System $103 2 payments
  9. LOKELMA $92 1 payment
  10. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter $48 1 payment
  11. Other $480 19 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 4 billing codes

Paid by Medicare

$2,824

Medicare's payments for the services billed

Medicare patients

36

Average age 80

Services billed

36

14 women, 22 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Heart failure 61%
Arthritis 58%
Diabetes 42%
Atrial fibrillation 39%
Chronic kidney disease 39%
COPD 31%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

162 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Acute Care in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record